Lifestream Pharma SA
Lifestream Pharma reported total assets of €1.38m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).
The score of Lifestream Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -15 % Total assets -11 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lifestream Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 18 Jun 2025
- Year ended 31 Dec 2023filed on 14 Jun 2024
- Year ended 31 Dec 2022filed on 31 May 2023
- Year ended 31 Dec 2021filed on 21 Jun 2022
Lifestream Pharma's financial analysis
- Solvency78.4%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lifestream Pharma
Lifestream Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0471.383.178
- VAT number
- BE0471383178
- Peppol
- Registered · 0208:0471383178 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 07 Mar 2000
- Registered office
- 7180 Seneffe
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Lifestream Pharma (SA) has been based in Seneffe since 2000, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 99,084 € and equity of €1.08m; its revenue is not published. Its solvency stands at 78.4%, above the median of its sector (43.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Lifestream Pharma
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Amoena Benelux Wholesale of pharmaceutical and medical goods Dilbeek · balance sheet €1.37m
- Pharmades Wholesale of pharmaceutical and medical goods Stabroek · balance sheet €1.41m
Frequently asked questions about Lifestream Pharma
What is the revenue of Lifestream Pharma?
Lifestream Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lifestream Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0471383178 for Lifestream Pharma, if the company is VAT-registered. Its company number (CBE) is 0471.383.178.
Where is the registered office of Lifestream Pharma?
According to the CBE register, the registered office of Lifestream Pharma is in 7180 Seneffe.
What is the equity of Lifestream Pharma?
At the close of the 2025 financial year, the equity of Lifestream Pharma amounts to 1,078,829 €, a solvency of 78.4% of total assets.
Who manages Lifestream Pharma?
The register lists 2 active mandates at Lifestream Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lifestream Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →